You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

What do patients want from their reliever (rescue) medication

Effective initial treatment1

Rapid onset of relief 2,3

A well-tolerated treatment3

Ventolin is highly effective for quick relief of asthma symptoms1 Ventolin starts working to relieve bronchospasm within 5 minutes and reaches peak effect in 10 minutes The tolerability of Ventolin has been demonstrated after 20 years of clinical use

Ventolin – a ‘first choice’ treatment in reversible obstructive airways disease3

Ventolin (inhaled salbutamol) is a selective beta2 adrenoceptor agonist indicated for the treatment or prevention of bronchospasm.

  • Ventolin provides short-acting (4 hours) bronchodilation in reversible airways obstruction due to asthma, chronic bronchitis and emphysema. 2

Ventolin may be used both to relieve asthma symptoms and to prevent them before exposure to a known trigger.2

Ventolin – bronchodilatory efficacy3

Short-acting β2 adrenergic agonists (SABAs), e.g. Ventolin, are recommended by GINA, as as-needed reliever medication of choice:1

  • At all ages
  • At all steps of asthma management

Clinical evidence

Data from clinical studies demonstrate that:

  • Inhaled Ventolin provides rapid and effective relief of bronchospasm when compared to oral salbutamol. 2,3
  • The efficacy of Ventolin has been confirmed in exercise-induced and severe asthma.3

Ventolin is well-tolerated irrespective of the formulation or route of administration.3

Read more

References

  1. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2015. Available from: http://www.ginasthma.org/. Accessed on January 12, 2016.
  2. Salbutamol (Inhaled Formulations). Global Datasheet, Version 25. 14 April 2014.
  3. Price AH, Clissold SP. Salbutamol in the 1980s. A reappraisal of its clinical efficacy. Drugs. 1989; 38(I):77-122.

Adverse events should be reported directly to the HPRA; Freepost, Pharmacovigilance Section, Health Products Regulatory Authority, Earlsfort Terrace, Dublin 2, Tel: +353 1 676 4971 medsafety@hpra.ie . Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.

Ventolin is a registered trademark of the GSK group of companies.